지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2023 .03
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Clinical and Molecular Hepatology
2024 .01
Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
Clinical and Molecular Hepatology
2022 .07
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Clinical and Molecular Hepatology
2021 .01
Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
Gut and Liver
2022 .07
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Clinical and Molecular Hepatology
2023 .02
The growing burden of non-alcoholic fatty liver disease on mortality
Clinical and Molecular Hepatology
2023 .04
Implications of comorbidities in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
Diabetes and Metabolism Journal
2022 .07
Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
Clinical and Molecular Hepatology
2024 .04
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
Clinical and Molecular Hepatology
2023 .04
Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study
Clinical Hypertension
2015 .01
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2021 .01
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Clinical and Molecular Hepatology
2022 .10
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Clinical and Molecular Hepatology
2023 .04
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Clinical and Molecular Hepatology
2023 .04
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Clinical and Molecular Hepatology
2022 .04
Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
Diabetes and Metabolism Journal
2023 .05
0